NEW YORK, September 7, 2022 /PRNewswire/ — NYU Langone Health today announced the appointment of internationally renowned physician and researcher, Oren Cahlon, MD, as senior vice president and associate clinical director. In this new role, Dr. Cahlon will advance the expansion, integration and operations of NYU Langone’s network and focus on strategic clinical centers throughout the system, including cardiovascular care, cancer, services for children, stroke services and inflammatory bowel disease. In addition, he will act as a strategic advisor to Faculty Group Practices (FGP) and will report directly to Andrew BrotmanMD, Executive Vice President and Vice Dean of Clinical Affairs and Strategy, Clinical Director
Additionally, Dr. Cahlon will maintain a clinical practice in the Department of Radiation Oncology at the Perlmutter Cancer Center, where he will contribute his experience in clinical care and research as an international expert in breast cancer treatment. He is currently the National Co-Principal Investigator of a national Phase III trial investigating the role of proton therapy in breast cancer and is the national recruiting leader for this trial.
“Dr. Cahlon has a track record of scientific excellence and transformative leadership, and we are confident he will enhance our clinical reach while maintaining our world-class level of care,” said Dr. Brotman.
About Dr. Cahlon
Dr. Cahlon comes to NYU Langone from Memorial Sloan Kettering Cancer Center (MSKCC), where he served as associate chief medical officer for strategic partnerships, senior vice president for clinical business development, and vice chair of the radiation oncology department. There, he led the strategy and implementation of a virtual health network to meet the clinical needs of MSKCC as an independent cancer center by developing new models of collaboration and partnerships with external physicians in various systems. health.
Dr. Cahlon received his medical degree from Mount Sinai School of Medicine, having finished first in his medical class. He then completed his internship and residency in radiation oncology at MSKCC and then began his career at Princeton Radiation Oncology, one of the largest providers of radiation therapy services in New Jersey.
SOURCE NYU Langone Health